{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:15:57Z","timestamp":1789676157384,"version":"4.0.1"},"reference-count":46,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Low- and lower-middle-income countries (LMICs) experience the highest mortality from gynecologic cancers globally. Previous literature has focused on the palliative management of cervical cancer and identified interventions that improve quality of life (QoL). There is limited research on the palliative management of ovarian cancer in LMICs, where high symptom burden and inconsistent access to health care present different challenges. This scoping review describes the state of the literature on palliative care for ovarian cancer in LMICs and highlights areas for future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses-ScR guidelines, we identified articles describing ovarian cancer burden and palliative symptom management in LMICs. Four databases (PubMed, Excerpta Medica database, Web of Science, Center for Agriculture and Biosciences International) were queried with terms developed by a health-sciences librarian.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 34 articles from nine LMICs were selected for full-text review. Three themes were identified in LMICs when compared with high-resource settings: (1) ovarian cancer frequently presents at advanced stages with poor disease-specific, functional, and social QoL; (2) access to comprehensive health systems and technology is limited, so cost-effective, home-based palliative care services provide an alternative in these settings; and (3) there are key differences in palliative treatment algorithms for advanced or recurrent ovarian cancer between LMICs and high-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Ovarian cancer can be a significant burden to patients in LMICs. When available, palliative care has effectively improved QoL; however, there are key differences in symptom management when compared with high-resource settings. Future work in LMICs settings should target cost-effective, evidence-based, and standardized approaches to palliative care for patients with ovarian cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00451","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:59:13Z","timestamp":1789675153000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Palliative Care for Ovarian Cancer in Low- and Lower-Middle-Income Countries: A Scoping Review"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6556","authenticated-orcid":true,"given":"Alekhya","family":"Gunturi","sequence":"first","affiliation":[{"name":"Department of Obstetrics &amp; Gynecology, Weill-Cornell Medical Center, New York City, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Onyebuchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynecology, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4098-613X","authenticated-orcid":true,"given":"Parisa N","family":"Fallah","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8815-1369","authenticated-orcid":true,"given":"Amanda","family":"Woodward","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0683-5436","authenticated-orcid":true,"given":"Sarah","family":"Slater","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Dana Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Randall","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Columbia University Irving Medical Center, New York City, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","unstructured":"Krakauer EL Kwete X Kane K et al: Cervical cancer-associated suffering: Estimating the palliative care needs of a highly vulnerable population. JCO Glob Oncol 10.1200\/GO.21.00025","DOI":"10.1200\/GO.21.00025"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.09.033"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15040406"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5233"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3432"},{"key":"e_1_3_5_7_2","volume-title":"The world by income and region. WDI\u2014The World by Income and Region","author":"World Bank Group","year":"2023","unstructured":"World Bank Group: The world by income and region. WDI\u2014The World by Income and Region, 2023. https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2018.0431"},{"key":"e_1_3_5_9_2","unstructured":"Eldermire E: A guide to evidence synthesis: 9. Risk of bias assessment. Available from: https:\/\/guides.library.cornell.edu\/evidence-synthesis\/bias"},{"key":"e_1_3_5_10_2","first-page":"CD012555","article-title":"Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults","volume":"9","author":"Sutherland A","year":"2018","unstructured":"Sutherland A, Naessens K, Plugge E, et al: Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. Cochrane Database Syst Rev 9:CD012555, 2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.4103\/jrms.JRMS_833_20"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0000000000000693"},{"key":"e_1_3_5_13_2","first-page":"9833","article-title":"Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: A placebo-controlled, triple-blind, randomized trial","volume":"30","author":"Ershadi R","year":"2022","unstructured":"Ershadi R, Vahedi M, Zadeh HK, et al: Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: A placebo-controlled, triple-blind, randomized trial. Support Care Cancer 30:9833-9840, 2022","journal-title":"Support Care Cancer"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2017.v10i11.18864"},{"key":"e_1_3_5_15_2","first-page":"21","article-title":"Recurrence of malignant pleural effusion following pleurodesis: Is there a difference between use of povidone-iodine or cyclophosphamide?","volume":"11","author":"Ogunrombi AB","year":"2014","unstructured":"Ogunrombi AB, Onakpoya UU, Ekrikpo U, et al: Recurrence of malignant pleural effusion following pleurodesis: Is there a difference between use of povidone-iodine or cyclophosphamide? Annal Afr Surg 11:21-24, 2014","journal-title":"Annal Afr Surg"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.03.017"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e318234f9ee"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.7.1969"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06735-3"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20156443"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2014.490"},{"key":"e_1_3_5_22_2","first-page":"167","article-title":"Triple combination of palliative oral metronomic chemotherapy in recurrent and metastatic epithelial ovarian cancer: A retrospective study","volume":"60","author":"Harsh KK","year":"2023","unstructured":"Harsh KK, Jakhar SL, Maheshwari G, et al: Triple combination of palliative oral metronomic chemotherapy in recurrent and metastatic epithelial ovarian cancer: A retrospective study. Indian J Cancer 60:167-172, 2023","journal-title":"Indian J Cancer"},{"key":"e_1_3_5_23_2","first-page":"135","article-title":"Palliative surgery for intestinal obstruction due to recurrent ovarian cancer","volume":"21","author":"Parveen Z","year":"2009","unstructured":"Parveen Z, Qureshi AN, Akbar M, et al: Palliative surgery for intestinal obstruction due to recurrent ovarian cancer. J Ayub Med Coll Abbottabad 21:135-136, 2009","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1179\/096992609X392213"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.12968\/ijpn.2021.27.7.362"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2010.501852"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-020-00558-5"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1186107"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.062"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32513-8"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.05.011"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2023.04.016"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0038"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.946"},{"key":"e_1_3_5_35_2","first-page":"14","article-title":"Treatment of chemotherapy-induced nausea in cancer patients","volume":"6","author":"Ryan JL","year":"2010","unstructured":"Ryan JL: Treatment of chemotherapy-induced nausea in cancer patients. Eur Oncol 6:14-16, 2010","journal-title":"Eur Oncol"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.11.018"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.17226\/21841"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.06.011"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2025.11.027"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113643"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-026-02048-6"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002368"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103754"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S555226"},{"key":"e_1_3_5_45_2","first-page":"e68275","article-title":"Assessing telehealth in palliative care: A systematic review of the effectiveness and challenges in rural and underserved areas","volume":"16","author":"Ghazal KY","year":"2024","unstructured":"Ghazal KY, Singh Beniwal S, Dhingra A: Assessing telehealth in palliative care: A systematic review of the effectiveness and challenges in rural and underserved areas. Cureus 16:e68275, 2024","journal-title":"Cureus"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.13964"},{"key":"e_1_3_5_47_2","unstructured":"World Health Organization: Palliative Care. WHO Fact Sheet 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:59:21Z","timestamp":1789675161000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1200\/GO-25-00451"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00451","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500451"}}